Dose dependent inhibition of REM sleep in normal volunteers by biperiden, a muscarinic antagonist
- 15 July 1991
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 30 (2) , 151-156
- https://doi.org/10.1016/0006-3223(91)90169-m
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison groupBiological Psychiatry, 1991
- Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteersPsychiatry Research, 1990
- EEG sleep studies in “pure” primary alcoholism during subacute withdrawal: Relationships to normal controls, age, and other clinical variablesBiological Psychiatry, 1990
- Muscarinic receptor subclassification and G-proteins: Significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neurolepticsBiological Psychiatry, 1989
- The Cholinergic Rapid Eye Movement Sleep Induction Test With RS-86Archives of General Psychiatry, 1989
- The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropineNeuropsychopharmacology, 1989
- Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypesEuropean Journal of Pharmacology, 1988
- The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonistEuropean Journal of Pharmacology, 1986
- Enhancement of desynchronized sleep signs after pontine microinjection of the muscarinic agonist bethanecholBrain Research, 1983
- Limbic cholinergic pathways involved in sleep and emotional behaviorExperimental Neurology, 1963